• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八种肿瘤错配修复基因的基因组分析。

Genome profiling of mismatch repair genes in eight types of tumors.

机构信息

Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China.

Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.

出版信息

Cell Cycle. 2021 Jun;20(11):1091-1106. doi: 10.1080/15384101.2021.1922160. Epub 2021 May 9.

DOI:10.1080/15384101.2021.1922160
PMID:33966609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8208120/
Abstract

Mismatch repair (MMR) plays an important role in the occurrence and development of tumors. At present, it is widely believed that MMR is a protective mechanism of tumors that plays a critical role in the progresses of cancer. In this study, 34 genes related to MMR selected from Gene Ontology (GO) database were scored by single sample Gene sets enrichment analysis (ssGSEA), and eight cancers were screened from 23 TCGA solid cancers to investigate the clinical significance of MMR score. MMR had different effects on the prognosis of the eight tumors, with a protective effect in three cancers and functioning as a risk factor in the remaining five cancers. We used unsupervised clustering to divide the patients into four clusters. We found that the immune and metabolic status of the four clusters were extremely different, among which cluster1 had the lowest tumor purity and the most complex microenvironment; this may explain its poor prognosis and immunotherapy effect. In summary, MMR scores can improve the predictive ability and provide effective guidance for immunotherapy in individual type of tumors.

摘要

错配修复(MMR)在肿瘤的发生和发展中起着重要作用。目前,广泛认为 MMR 是肿瘤的一种保护机制,在癌症的进展中起着关键作用。在这项研究中,从基因本体论(GO)数据库中选择了 34 个与 MMR 相关的基因,通过单样本基因集富集分析(ssGSEA)进行评分,并从 23 种 TCGA 实体瘤中筛选出 8 种癌症,以研究 MMR 评分的临床意义。MMR 对 8 种肿瘤的预后有不同的影响,在 3 种肿瘤中具有保护作用,而在其余 5 种肿瘤中则作为危险因素发挥作用。我们使用无监督聚类将患者分为 4 个聚类。我们发现,这四个聚类的免疫和代谢状态差异极大,其中聚类 1 的肿瘤纯度最低,微环境最复杂;这可能解释了其预后不良和免疫治疗效果不佳。总之,MMR 评分可以提高预测能力,并为个体类型的肿瘤的免疫治疗提供有效指导。

相似文献

1
Genome profiling of mismatch repair genes in eight types of tumors.八种肿瘤错配修复基因的基因组分析。
Cell Cycle. 2021 Jun;20(11):1091-1106. doi: 10.1080/15384101.2021.1922160. Epub 2021 May 9.
2
Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.遗传性和散发性错配修复缺陷型子宫内膜癌具有独特的免疫景观。
Front Immunol. 2020 Jan 9;10:3023. doi: 10.3389/fimmu.2019.03023. eCollection 2019.
3
Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.赖氨酸特异性去甲基化酶 6A(KDM6A)与错配修复(MMR)状态的联合是结直肠癌的一个潜在预后因素。
Cancer Med. 2021 Jan;10(1):317-324. doi: 10.1002/cam4.3602. Epub 2020 Nov 11.
4
IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer.IGSF6 是一种新型生物标志物,可用于评估错配修复功能健全的结直肠癌中的免疫浸润情况。
Sci Rep. 2023 Nov 21;13(1):20368. doi: 10.1038/s41598-023-47739-9.
5
CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.CX3CR1 在结直肠癌肿瘤微环境中作为一种保护性生物标志物。
Front Immunol. 2022 Jan 24;12:758040. doi: 10.3389/fimmu.2021.758040. eCollection 2021.
6
The pan-cancer multi-omics landscape of key genes of sialylation combined with RNA-sequencing validation.癌症全景多组学中唾液酸化关键基因的综合分析与 RNA 测序验证。
Comput Biol Med. 2023 Nov;166:107556. doi: 10.1016/j.compbiomed.2023.107556. Epub 2023 Sep 30.
7
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?为什么免疫疗法对微卫星高度不稳定/错配修复缺陷(MSI/MMRD)肿瘤患者有效(或无效)?
Bull Cancer. 2019 Feb;106(2):105-113. doi: 10.1016/j.bulcan.2018.08.007. Epub 2018 Oct 17.
8
Approaches to diagnose DNA mismatch repair gene defects in cancer.癌症中DNA错配修复基因缺陷的诊断方法。
DNA Repair (Amst). 2016 Feb;38:147-154. doi: 10.1016/j.dnarep.2015.11.022. Epub 2015 Dec 8.
9
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中的预后基因鉴定。
Front Immunol. 2021 Apr 7;12:653836. doi: 10.3389/fimmu.2021.653836. eCollection 2021.
10
Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.鉴定免疫相关长链非编码 RNA 以预测膀胱癌的预后和免疫治疗反应。
Aging (Albany NY). 2020 Nov 18;12(22):23306-23325. doi: 10.18632/aging.104115.

引用本文的文献

1
Characterization of a predictive signature for tumor microenvironment and immunotherapy response in hepatocellular carcinoma involving neutrophil extracellular traps.肝细胞癌中涉及中性粒细胞胞外陷阱的肿瘤微环境和免疫治疗反应预测特征的表征
Heliyon. 2024 May 8;10(10):e30827. doi: 10.1016/j.heliyon.2024.e30827. eCollection 2024 May 30.

本文引用的文献

1
Prognostic Implications of Pan-Cancer CMTM6 Expression and Its Relationship with the Immune Microenvironment.泛癌CMTM6表达的预后意义及其与免疫微环境的关系
Front Oncol. 2021 Jan 20;10:585961. doi: 10.3389/fonc.2020.585961. eCollection 2020.
2
An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment.一项综合泛癌分析揭示LCN2是肿瘤微环境中的一种致癌免疫蛋白。
Front Oncol. 2020 Dec 23;10:605097. doi: 10.3389/fonc.2020.605097. eCollection 2020.
3
A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.一个由九个长链非编码 RNA 组成的标志物可预测接受紫杉烷和蒽环类药物为基础的新辅助化疗的 HER2 阴性乳腺癌患者的远处无复发生存率。
Biochem Pharmacol. 2021 Jul;189:114285. doi: 10.1016/j.bcp.2020.114285. Epub 2020 Oct 15.
4
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.除BRCA外的遗传性乳腺癌和/或卵巢癌综合征的二级预防
J Oncol. 2020 Jul 14;2020:6384190. doi: 10.1155/2020/6384190. eCollection 2020.
5
TBtools: An Integrative Toolkit Developed for Interactive Analyses of Big Biological Data.TBtools:一个用于生物大数据交互式分析的集成工具包。
Mol Plant. 2020 Aug 3;13(8):1194-1202. doi: 10.1016/j.molp.2020.06.009. Epub 2020 Jun 23.
6
Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.针对DNA损伤反应改变的潜在合成致死药物靶点的泛癌分析
Front Oncol. 2019 Oct 25;9:1136. doi: 10.3389/fonc.2019.01136. eCollection 2019.
7
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages.转录因子 WT1 表达定义的基质细胞龛介导向腔驻留巨噬细胞的编程和稳态。
Immunity. 2019 Jul 16;51(1):119-130.e5. doi: 10.1016/j.immuni.2019.05.010. Epub 2019 Jun 20.
8
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy.错配修复缺陷/微卫星不稳定高作为抗 PD-1/PD-L1 免疫治疗疗效的预测指标。
J Hematol Oncol. 2019 May 31;12(1):54. doi: 10.1186/s13045-019-0738-1.
9
Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche.淋巴内皮细胞是被膜下窦巨噬细胞生态位的必需组成部分。
Immunity. 2019 Jun 18;50(6):1453-1466.e4. doi: 10.1016/j.immuni.2019.04.002. Epub 2019 Apr 30.
10
The Zebrafish as an Emerging Model to Study DNA Damage in Aging, Cancer and Other Diseases.斑马鱼作为研究衰老、癌症及其他疾病中DNA损伤的新兴模型。
Front Cell Dev Biol. 2019 Jan 10;6:178. doi: 10.3389/fcell.2018.00178. eCollection 2018.